Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 8 of 8 descriptions
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Fentanyl | 1件: Fentanyl Fentanyl (Apo-fentanyl Matrix) | 1件: Fentanyl
Fentanyl
(Fentanyl) 💬1. Fentanyl
| 1件: OPRM1 OPRM1 💬1. Fentanyl
| 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 3件: 46 46, 70, 215 💬
| ||||||||||||||||||||||||||
2 | Fentanyl (High Dose) | 1件: Fentanyl Fentanyl (Apo-fentanyl Matrix) | 1件: Fentanyl
Fentanyl
(Fentanyl) 💬2. Fentanyl (High Dose)
| 1件: OPRM1 OPRM1 💬2. Fentanyl (High Dose)
| 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 215 215 💬2. Fentanyl (High Dose)
| ||||||||||||||||||||||||||
3 | Fentanyl (Low Dose) | 1件: Fentanyl Fentanyl (Apo-fentanyl Matrix) | 1件: Fentanyl
Fentanyl
(Fentanyl) 💬3. Fentanyl (Low Dose)
| 1件: OPRM1 OPRM1 💬3. Fentanyl (Low Dose)
| 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 215 215 💬3. Fentanyl (Low Dose)
| ||||||||||||||||||||||||||
4 | Fentanyl (Low Dose) + Dexmedetomidine | 2件: Dexmedetomidine Dexmedetomidine,Fentanyl (Apo-fentanyl Matrix) | 2件: Fentanyl
Fentanyl
(Fentanyl),Dexmedetomidine 💬 4. Fentanyl (Low Dose) + Dexmedetomidine
| 4件: ADRA2A ADRA2A,ADRA2B, ADRA2C, OPRM1 💬 | 4件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PK ... | 1件: 215 215 💬4. Fentanyl (Low Dose) + Dexmedetomidine
| ||||||||||||||||||||||||||
5 | Fentanyl transdermal patch | 1件: Fentanyl Fentanyl (Apo-fentanyl Matrix) | 1件: Fentanyl
Fentanyl
(Fentanyl) 💬5. Fentanyl transdermal patch
| 1件: OPRM1 OPRM1 💬5. Fentanyl transdermal patch
| 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬5. Fentanyl transdermal patch
| ||||||||||||||||||||||||||
6 | Multi-modal pain management [Fentanyl] | 1件: Fentanyl Fentanyl (Apo-fentanyl Matrix) | 1件: Fentanyl
Fentanyl
(Fentanyl) 💬6. Multi-modal pain management [Fentanyl]
| 1件: OPRM1 OPRM1 💬6. Multi-modal pain management [Fentanyl]
| 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 💬6. Multi-modal pain management [Fentanyl]
| ||||||||||||||||||||||||||
7 | Standard analgesia use [Fentanyl] | 1件: Fentanyl Fentanyl (Apo-fentanyl Matrix) | 1件: Fentanyl
Fentanyl
(Fentanyl) 💬7. Standard analgesia use [Fentanyl]
| 1件: OPRM1 OPRM1 💬7. Standard analgesia use [Fentanyl]
| 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 💬7. Standard analgesia use [Fentanyl]
| ||||||||||||||||||||||||||
8 | Transdermal fentanyl matrix, gabapentin | 2件: Fentanyl Fentanyl (Apo-fentanyl Matrix),Gabapentin | 2件: Fentanyl
Fentanyl
(Fentanyl),Gabapentin 💬 8. Transdermal fentanyl matrix, gabapentin
| 6件: CACNA2D1 CACNA2D1,CACNA2D2, CACNA2D3, CACNA2D4, OPRM1, SLC6A1 💬 8. Transdermal fentanyl matrix, gabapentin
| 12件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 12件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardia ... | 1件: 70 70 💬8. Transdermal fentanyl matrix, gabapentin
|